GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Induction Healthcare Group PLC (LSE:INHC) » Definitions » Debt-to-EBITDA

Induction Healthcare Group (LSE:INHC) Debt-to-EBITDA : 0.00 (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Induction Healthcare Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Induction Healthcare Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was £0.00 Mil. Induction Healthcare Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was £0.00 Mil. Induction Healthcare Group's annualized EBITDA for the quarter that ended in Sep. 2023 was £-0.53 Mil. Induction Healthcare Group's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Induction Healthcare Group's Debt-to-EBITDA or its related term are showing as below:

LSE:INHC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.01   Med: -0.01   Max: -0.01
Current: -0.01

During the past 5 years, the highest Debt-to-EBITDA Ratio of Induction Healthcare Group was -0.01. The lowest was -0.01. And the median was -0.01.

LSE:INHC's Debt-to-EBITDA is ranked worse than
100% of 426 companies
in the Healthcare Providers & Services industry
Industry Median: 2.56 vs LSE:INHC: -0.01

Induction Healthcare Group Debt-to-EBITDA Historical Data

The historical data trend for Induction Healthcare Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Induction Healthcare Group Debt-to-EBITDA Chart

Induction Healthcare Group Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
N/A - - - -0.01

Induction Healthcare Group Semi-Annual Data
Sep18 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.01 -

Competitive Comparison of Induction Healthcare Group's Debt-to-EBITDA

For the Health Information Services subindustry, Induction Healthcare Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Induction Healthcare Group's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Induction Healthcare Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Induction Healthcare Group's Debt-to-EBITDA falls into.



Induction Healthcare Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Induction Healthcare Group's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.072 + 0.056) / -12.534
=-0.01

Induction Healthcare Group's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2023) EBITDA data.


Induction Healthcare Group  (LSE:INHC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Induction Healthcare Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Induction Healthcare Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Induction Healthcare Group (LSE:INHC) Business Description

Traded in Other Exchanges
N/A
Address
C/o Pinsent Masons, 30 Crown Place, Earl Street, London, GBR, EC2A 4ES
Induction Healthcare Group PLC is a healthcare technology company focused on streamlining the delivery of care by Healthcare Professionals. The company's mobile application module Induction Switch is an app that provides a directory allowing Healthcare Professionals to find extension numbers, messaging, and administration portals to share and view hospital guidelines. The company's products power remote consultations, capture patient-reported data and empower patients to self-manage their care pathway. Geographically, it operates in the United Kingdom, Europe, the United States and the Rest of the world, out of which the majority of revenue is derived from the United Kingdom.

Induction Healthcare Group (LSE:INHC) Headlines

No Headlines